SPEEDA RABIES VACCINE FREEZE-DRIED FOR HUMAN USE (VERO CELLS)

Dosage

Children: Refer to pharmacological literature for specific dosing guidelines based on the drug and condition being treated.

Adults: Refer to pharmacological literature for specific dosing guidelines based on the drug and condition being treated.

Mechanism of action

Cells perform their functions through complex biochemical processes including signal transduction, gene expression, and energy metabolism. These processes are regulated by various molecules such as enzymes, hormones, and signaling pathways that facilitate communication within and between cells.

Pharmacodynamics

Pharmacodynamics in the context of cells refers to how cells respond to various drugs or stimuli. This includes receptor activation, intracellular signaling cascades, and modifications of cellular behavior such as proliferation, differentiation, or apoptosis. The response can vary greatly depending on the cell type and the specific conditions.

Pharmacokinetics

Pharmacokinetics involves how substances are absorbed, distributed, metabolized, and excreted by cells. For drugs, this includes how they enter cells, their distribution within cellular compartments, metabolic conversion to active or inactive forms, and ultimate removal from the body. Each of these processes significantly influences the efficacy and safety of pharmacological interventions.

Pregnancy

Cell therapy and manipulation during pregnancy require caution. The effects on fetal development depend on the type of cells used and the intended application.

Breast-feeding

The implications of cell therapy during breastfeeding are not well studied, and caution is advised.

Storage

Cells should be stored in controlled environments, typically at low temperatures to maintain viability, such as liquid nitrogen for cryopreserved cells.

Indications

• Allergic conditions
• Autoimmune diseases
• Inflammatory conditions
• Certain cancers
• Asthma exacerbations
• Chronic obstructive pulmonary disease (COPD)

Dosage

Children: Refer to the BNF for Children for pediatric dosing recommendations, as these will depend on the child's age, weight, and specific clinical condition.

Adults: Refer to the specific BNF for appropriate dosing information based on the condition being treated. Dosage varies widely depending on the severity of the condition and the specific formulation used.

Mechanism of action

Dexamethasone binds to glucocorticoid receptors in the cytoplasm of target cells, leading to the formation of a receptor-hormone complex that translocates to the nucleus. This complex then modulates gene expression, resulting in the inhibition of pro-inflammatory cytokines and mediators, thus exerting potent anti-inflammatory and immunosuppressive effects.

Pharmacodynamics

Dexamethasone exhibits anti-inflammatory properties by reducing the migration of leukocytes and the production of cytokines. It suppresses the immune response and decreases capillary permeability, which helps in alleviating symptoms associated with inflammation. Its effects can be observed in various conditions, including autoimmune disorders, asthma, and as part of anti-cancer regimens.

Pharmacokinetics

Dexamethasone is rapidly absorbed when administered orally and reaches peak plasma concentrations within 1 to 2 hours. It has a high protein binding rate, primarily to albumin and corticosteroid-binding globulin. The drug is metabolized predominantly in the liver and has a half-life of approximately 3 to 4 hours. It is excreted mainly through urine as metabolites.

Pregnancy

Safety during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is unknown whether vero is excreted in human milk. Caution should be exercised when administered to nursing women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.